Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.87 USD 0.34% Market Closed
Market Cap: 337.5m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kamada Ltd
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Common Stock
$15m
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
5%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Common Stock
$5m
CAGR 3-Years
19%
CAGR 5-Years
26%
CAGR 10-Years
N/A
B
BioLine RX Ltd
TASE:BLRX
Common Stock
$31.4m
CAGR 3-Years
19%
CAGR 5-Years
52%
CAGR 10-Years
41%
Urogen Pharma Ltd
NASDAQ:URGN
Common Stock
$115k
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Common Stock
$1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Common Stock
â‚Ş303.1m
CAGR 3-Years
8%
CAGR 5-Years
29%
CAGR 10-Years
27%
No Stocks Found

Kamada Ltd
Glance View

Market Cap
337.4m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.35 USD
Overvaluation 9%
Intrinsic Value
Price

See Also

What is Kamada Ltd's Common Stock?
Common Stock
15m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's Common Stock amounts to 15m USD.

What is Kamada Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
5%

Over the last year, the Common Stock growth was 0%. The average annual Common Stock growth rates for Kamada Ltd have been 9% over the past three years , 8% over the past five years , and 5% over the past ten years .

Back to Top